Your mention of missteps and past imperfections curiously leaves out any mention of the Mako attack which continues to this day. Day after day. Do you not think this has had a substantial effect on the current situation?
A major phase 2b trial failure, terrible handling of information disclosure in that failed trial, major milestone misses, an anemic partnership deal ($420K in revenues so far), and ever deteriorating financing deals have led the stock price on a downward slide of destruction. All good will toward this company has been used up.
Market Data 
Markets 
AI
